Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Vein-Blocking procedure ease chronic pelvic pain?

NCT ID NCT07735156

Symptom relief Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial investigates whether a minimally invasive procedure called endovascular embolization can relieve chronic pelvic pain in women with pelvic congestion syndrome. The study will enroll 30 women who have had pelvic pain for more than six months and have imaging evidence of faulty pelvic veins. Researchers will measure changes in pain levels and quality of life six months after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a minimally invasive procedure called endovascular embolization (ovarian vein embolization) to block faulty veins in the pelvis
What this could lead to
If it works, this could offer a safe, effective treatment option for women with chronic pelvic pain caused by pelvic congestion syndrome.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to all women. The procedure carries risks like bleeding, infection, or vein damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18 years or older. * Chronic pelvic pain for more than 6 months. * Clinical suspicion of pelvic congestion syndrome. * Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography. * Patients willing to undergo endovascular embolization. * Written informed consent obtained Exclusion Criteria: * Pregnancy. * Active pelvic inflammatory disease. * Known pelvic malignancy. * Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids). * Contraindication to iodinated contrast media. * Severe renal impairment. * Uncorrectable coagulation disorders. * Refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pelvic congestion syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pelvic congestion syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pelvic congestion syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Interventional radiology unit, Sohag university hospital

    RECRUITING

    Sohag, Sohag Governorate, 82524, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.